75140-04-4 Usage
Uses
Used in Oncology:
DANTHRON is used as an anti-tumor agent for its ability to inhibit the growth of various cancer cells, including those in breast, colon, and lung cancers. Its potential as a cancer treatment is attributed to its capacity to interfere with the proliferation and survival of cancer cells, thereby offering a promising avenue for therapeutic intervention in oncology.
Used in Inflammatory Disease Treatment:
In the field of inflammatory disease treatment, DANTHRON is utilized for its anti-inflammatory properties, which include the suppression of inflammatory cytokines and nitric oxide production. This makes it a candidate for the treatment of inflammatory conditions such as rheumatoid arthritis and other autoimmune disorders, where modulation of the immune response is critical.
Further research is necessary to fully understand the mechanisms by which DANTHRON exerts its effects and to determine its safety and efficacy in clinical settings. As our understanding of 4-(3-HYDROXYANILINO)-1,2-DIHYDRONAPHTHALENE-1,2-DIONE grows, so too may its applications in various medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 75140-04-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,1,4 and 0 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 75140-04:
(7*7)+(6*5)+(5*1)+(4*4)+(3*0)+(2*0)+(1*4)=104
104 % 10 = 4
So 75140-04-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H11NO3/c18-11-5-3-4-10(8-11)17-14-9-15(19)16(20)13-7-2-1-6-12(13)14/h1-9,17-18H
75140-04-4Relevant academic research and scientific papers
HEAT SHOCK PROTEIN 90 INHIBITORS, METHODS OF PREPARING SAME, AND METHODS FOR THEIR USE
-
Page/Page column 14, (2010/04/28)
Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors are disclosed. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases and conditions, such as inflammation and neurodegenerative disorders. Methods of treating and preventing cancer and other Hsp90 related diseases and conditions are disclosed that include administering to the subject a therapeutically effective amount of an Hsp90 inhibitor. Methods of preparing the novel Hsp90 inhibitors are also provided.
Xi:Irritant;
